Chakma J K, Girdhar A, Natrajan M, Kumar A, Girdhar B K
National JALMA Institute for Leprosy and Other Mycobacterial Diseases, ICMR, Tajganj, Agra 282 001, India.
Lepr Rev. 2008 Sep;79(3):331-4.
A lepromatous patient treated with dapsone in the pre-MDT era to the point of smear negativity (> 6 years), relapsed 5 years after stopping treatment. He was then put on WHO-MDT for multibacillary (MB) leprosy, and was treated again; he had negative slit skin smears (3 years). He again presented with a relapse of leprosy 17 years after stopping treatment, and this time he presented with borderline leprosy in reaction.
一名在多药联合化疗（MDT）时代之前接受氨苯砜治疗直至涂片转阴（超过6年）的瘤型麻风患者，在停药5年后复发。随后他开始接受世界卫生组织针对多菌型（MB）麻风病的MDT治疗，并再次接受治疗；他的皮肤涂片检查结果为阴性（3年）。在停药17年后，他再次出现麻风病复发，此次表现为界线类麻风反应。
